Found 15 results

Name Type of Offering Accepted Date
TRXADE GROUP, INC. See All Filings
D 2014-08-26
Amount To Be Raised $375,000
Associated Brokers / Dealers N/A
CIK Number 0001382574
Filed Document 0001250853-14-000110
Exclusions or Exemptions 506b
Accepted Date 2014-08-26
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business FLORIDA
Revenue or Assets $1 - $1,000,000
Type of Security Equity
TRXADE GROUP, INC. See All Filings
D 2017-01-17 14:46:33
Amount To Be Raised $15,000
Associated Brokers / Dealers N/A
CIK Number 0001382574
Filed Document 0001382574-17-000001
Exclusions or Exemptions 506b
Accepted Date 2017-01-17 14:46:33
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business FLORIDA
Revenue or Assets Decline to Disclose
Type of Security Equity
TRXADE GROUP, INC. See All Filings
D 2018-07-13 15:22:32
Amount To Be Raised $2,000,000
Associated Brokers / Dealers N/A
CIK Number 0001382574
Filed Document 0001445866-18-000734
Exclusions or Exemptions 506b
Accepted Date 2018-07-13 15:22:32
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business FLORIDA
Revenue or Assets Decline to Disclose
Type of Security Equity
TRXADE GROUP, INC. See All Filings
D 2014-08-26
Amount To Be Raised $64,900,000
Associated Brokers / Dealers N/A
CIK Number 0001382574
Filed Document 0001250853-14-000109
Exclusions or Exemptions 506b
Accepted Date 2014-08-26
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business FLORIDA
Revenue or Assets $1 - $1,000,000
Type of Security Equity
TRXADE GROUP, INC. See All Filings
D 2014-10-20
Amount To Be Raised $2,000,000
Associated Brokers / Dealers N/A
CIK Number 0001382574
Filed Document 0001250853-14-000128
Exclusions or Exemptions 506b
Accepted Date 2014-10-20
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business FLORIDA
Revenue or Assets $1,000,001 - $5,000,000
Type of Security Equity
Scienture Holdings, Inc. See All Filings
D/A 2025-08-07 17:30:42
Amount To Be Raised $3,000,000
Associated Brokers / Dealers N/A
CIK Number 0001382574
Filed Document 0001641172-25-022629
Exclusions or Exemptions 506b
Accepted Date 2025-08-07 17:30:42
Type of Offering D/A
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business NEW YORK
Revenue or Assets Decline to Disclose
Type of Security Equity
TRXADE GROUP, INC. See All Filings
D 2015-11-02
Amount To Be Raised $1,505,000
Associated Brokers / Dealers N/A
CIK Number 0001382574
Filed Document 0001382574-15-000002
Exclusions or Exemptions 506b
Accepted Date 2015-11-02
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business FLORIDA
Revenue or Assets Decline to Disclose
Type of Security Equity
Scienture Holdings, Inc. Artboard 1
See All Filings
1-A 2024-09-25 16:05:15
Amount To Be Raised $20,000,000
Associated Brokers / Dealers N/A
CIK Number 0001382574
Filed Document 0001493152-24-038104
Accepted Date 2024-09-25 16:05:15
Type of Offering 1-A
Industry WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
Offering Tier Tier2
Principal Place of Business FLORIDA
Revenue or Assets $18,699.00
State of Jurisdiction DELAWARE
Type of Security Equity (common or preferred stock)
Scienture Holdings, Inc. See All Filings
D 2024-12-19 16:27:30
Amount To Be Raised $3,333,333
Associated Brokers / Dealers N/A
CIK Number 0001382574
Filed Document 0001493152-24-050785
Exclusions or Exemptions 506b
Accepted Date 2024-12-19 16:27:30
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business FLORIDA
Revenue or Assets Decline to Disclose
Type of Security Equity
Scienture Holdings, Inc. Artboard 1
See All Filings
1-A/A 2024-11-05 19:14:01
Amount To Be Raised $20,000,000
Associated Brokers / Dealers N/A
CIK Number 0001382574
Filed Document 0001493152-24-043709
Accepted Date 2024-11-05 19:14:01
Type of Offering 1-A/A
Industry WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
Offering Tier Tier2
Principal Place of Business FLORIDA
Revenue or Assets $18,699.00
State of Jurisdiction DELAWARE
Type of Security Equity (common or preferred stock)
TRXADE GROUP, INC. See All Filings
D 2017-03-21 16:33:29
Amount To Be Raised $250,875
Associated Brokers / Dealers N/A
CIK Number 0001382574
Filed Document 0001382574-17-000002
Exclusions or Exemptions 506b
Accepted Date 2017-03-21 16:33:29
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business FLORIDA
Revenue or Assets Decline to Disclose
Type of Security Equity
TRXADE GROUP, INC. See All Filings
D 2018-10-25 15:23:05
Amount To Be Raised $300,000
Associated Brokers / Dealers N/A
CIK Number 0001382574
Filed Document 0001445866-18-001151
Exclusions or Exemptions 506b
Accepted Date 2018-10-25 15:23:05
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business FLORIDA
Revenue or Assets Decline to Disclose
Type of Security Debt
TRXADE GROUP, INC. See All Filings
D 2018-11-14 15:50:30
Amount To Be Raised $1,000,000
Associated Brokers / Dealers N/A
CIK Number 0001382574
Filed Document 0001445866-18-001245
Exclusions or Exemptions 506b
Accepted Date 2018-11-14 15:50:30
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business FLORIDA
Revenue or Assets Decline to Disclose
Type of Security Equity
TRXADE GROUP, INC. See All Filings
D 2019-08-08 13:24:52
Amount To Be Raised $2,000,000
Associated Brokers / Dealers N/A
CIK Number 0001382574
Filed Document 0001493152-19-011861
Exclusions or Exemptions 506b
Accepted Date 2019-08-08 13:24:52
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business FLORIDA
Revenue or Assets Decline to Disclose
Type of Security Equity
Scienture Holdings, Inc. See All Filings
D 2025-08-01 12:54:23
Amount To Be Raised $3,000,000
Associated Brokers / Dealers N/A
CIK Number 0001382574
Filed Document 0001641172-25-021856
Exclusions or Exemptions 506b
Accepted Date 2025-08-01 12:54:23
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business NEW YORK
Revenue or Assets Decline to Disclose
Type of Security Equity